Taryn L. Mayes

Best Publications

• The Treatment for Adolescents with Depression Study (TADS): Long-term effectiveness and safety outcomes

  John S. March;Susan Silva;Stephen Petrycki;John Curry

  854
  Citations

• Suicide attempts and nonsuicidal self-injury in the treatment of resistant depression in adolescents: findings from the TORDIA study.

  Joan Rosenbaum Asarnow;Giovanna Porta;Anthony Spirito;Graham J Emslie

  812
  Citations

• Anhedonia Predicts Poorer Recovery among Youth with Selective Serotonin Reuptake Inhibitor Treatment-Resistant Depression

  Dana L. McMakin;Thomas M. Olino;Giovanna Porta;Laura J. Dietz

  494
  Citations

• Protecting Adolescents From Self-Harm: A Critical Review of Intervention Studies

  David A. Brent;Dana L. McMakin;Betsy D. Kennard;Tina R. Goldstein

  298
  Citations

• Recovery and Recurrence Following Treatment for Adolescent Major Depression

  John Curry;Susan Silva;Paul Rohde;Golda Ginsburg

  296
  Citations

• Psychometric properties of the children's depression rating Scale-Revised in adolescents

  Taryn L. Mayes;Ira H. Bernstein;Charlotte L. Haley;Betsy D. Kennard

  273
  Citations

• Predictors of Spontaneous and Systematically Assessed Suicidal Adverse Events in the Treatment of SSRI- Resistant Depression in Adolescents (TORDIA) Study

  David A. Brent;Graham J. Emslie;Greg N. Clarke;Joan Asarnow

  265
  Citations

• Review of the efficacy and safety of antidepressants in youth depression.

  Amy H. Cheung;Graham J. Emslie;Taryn L. Mayes

  253
  Citations

• Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: Predictors and moderators of treatment response

  Joan Rosenbaum Asarnow;Graham Emslie;Greg Clarke;Karen Dineen Wagner

  235
  Citations

• Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents.

  Graham J. Emslie;Beth D. Kennard;Taryn L. Mayes;Jeanne Nightingale-Teresi

  229
  Citations

• Treatment of Resistant Depression in Adolescents (TORDIA): Week 24 Outcomes

  Graham J. Emslie;Taryn Mayes;Giovanna Porta;Benedetto Vitiello

  225
  Citations

• Treatment for Adolescents with Depression Study (TADS): safety results.

  Graham Emslie;Graham Emslie;Graham Emslie;Christopher Kratochvil;Benedetto Vitiello;Susan Silva

  225
  Citations

• Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial.

  Manish K Jha;Abu Taher M Minhajuddin;Bharathi Gadad;Tracy L Greer

  219
  Citations

• Fluoxetine in child and adolescent depression: Acute and maintenance treatment

  Graham J. Emslie;A. John Rush;Warren A. Weinberg;Robert A. Kowatch

  215
  Citations

• Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks

  Bharathi S. Gadad;Manish K. Jha;Andrew Czysz;Jennifer L. Furman

  214
  Citations

• Suicidal events in the Treatment for Adolescents With Depression Study (TADS).

  Benedetto Vitiello;Susan G. Silva;Paul Rohde;Christopher J. Kratochvil

  174
  Citations

• The treatment for adolescents with depression study (TADS): Outcomes over 1 year of naturalistic follow-up

  John March;Susan Silva;John Curry;Karen Wells

  173
  Citations

• Association of FKBP5 Polymorphisms With Suicidal Events in the Treatment of Resistant Depression in Adolescents (TORDIA) Study

  David A. Brent;Nadine Melhem;Robert Ferrell;Graham Emslie

  172
  Citations

• Sequential Treatment With Fluoxetine and Relapse-Prevention CBT to Improve Outcomes in Pediatric Depression

  Beth Kennard;Graham J Emslie;Taryn L. Mayes;Paul A Nakonezny

  164
  Citations

• Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.

  Benedetto Vitiello;Graham J Emslie;Gregory Clarke;Karen Dineen Wagner

  160
  Citations